Capital Medical University
353
55
64
128
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.3%
8 terminated/withdrawn out of 353 trials
94.1%
+7.5% vs industry average
15%
53 trials in Phase 3/4
5%
6 of 128 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (353)
3M-6D Educational Intervention to Improve LLM-Assisted Medical Consultation in Neurology Outpatients
Role: lead
Screening for Hyperopic Reserve in Kindergarten
Role: collaborator
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria
Role: collaborator
Personalized Accelerated iTBS Versus Sham for Major Depressive Disorder
Role: lead
Safety and Efficacy of Carotid Artery Stenting Combined With Intermittent Hypoxia Intervention in Patients With Severe Internal Carotid Artery Stenosis
Role: lead
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Role: lead
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF
Role: lead
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
Role: lead
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
Role: lead
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
Role: lead
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
Role: lead
Manual Thrombus Aspiration During PCI in STEMI With Angiographically Evident Thrombus
Role: collaborator
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
Role: lead
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
Role: lead
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
Role: lead
Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis
Role: lead
Postprocedural Bed-Rest Strategies After Transfemoral Venous Interventions
Role: lead
Improving the Reliability of LLMs as Medical Assistants for the General Public
Role: lead
Efficacy and Safety of Inhaled Peramivir Solution for the Treatment of Adults With Uncomplicated Influenza
Role: lead
Artificial Intelligence Support for Stroke
Role: lead